A
Amanda Belkin
Researcher at National Jewish Health
Publications - 13
Citations - 218
Amanda Belkin is an academic researcher from National Jewish Health. The author has contributed to research in topics: Rasch model & Idiopathic pulmonary fibrosis. The author has an hindex of 7, co-authored 13 publications receiving 199 citations.
Papers
More filters
Journal ArticleDOI
A qualitative study of informal caregivers’ perspectives on the effects of idiopathic pulmonary fibrosis
TL;DR: A conceptual framework of the IC's journey with a patient with IPF was developed and includes suggestions for interventions that might ease the burdens ICs endure while caring for their patient-loved ones.
Journal ArticleDOI
Health-related quality of life in idiopathic pulmonary fibrosis: where are we now?
Amanda Belkin,Jeffrey J. Swigris +1 more
TL;DR: Current knowledge of health-related quality of life (HRQL) assessment in idiopathic pulmonary fibrosis (IPF) is summarized, with an emphasis on reviewing available data on HRQL instruments, operationalizing HRQL assessment in IPF research and interventions that show promise for improving HRQL in patients with IPF.
Journal ArticleDOI
Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA).
Janelle Yorke,Lisa Spencer,Annette Duck,Sarah Ratcliffe,G NgMan Kwong,Mark S Longshaw,Amanda Belkin,Jeffrey J. Swigris +7 more
TL;DR: The reliability and validity of the substantially shortened ATAQ-IPF-cA are acceptable and comparable to the original instrument and are recommended for use in IPF studies in which participants are enrolled from the USA and UK.
Journal ArticleDOI
Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis
Jeffrey J. Swigris,David L. Streiner,Kevin K. Brown,Amanda Belkin,Kathy E. Green,Frederick S. Wamboldt +5 more
TL;DR: The first 21 physical activity items from the University of California San Diego Shortness of Breath Questionnaire compose a unidimensional dyspnea-with-activity scale and are both sensibly ordered and distinguished from each other by their METS values.
Journal ArticleDOI
Protocol for a mixed-methods study of supplemental oxygen in pulmonary fibrosis
Amanda Belkin,Kaitlin Fier,Karen Albright,Susan Baird,Brenda Crowe,Linda Eres,Marjorie Korn,Leslie Maginn,Mark McCormick,Elisabeth Dowling Root,Thomas Vierzba,Frederick S. Wamboldt,Jeffrey J. Swigris +12 more
TL;DR: A longitudinal, pre-/post- study in which patient-reported outcome and activity data will be collected at baseline, immediately before daytime supplemental oxygen is initiated, and then once and again 9–12 months later, to assess the trajectories of outcomes over time.